An isoform-specific RUNX1C-BTG2 axis governs AML quiescence and chemoresistance.

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference.

Redefining Value in Orthopedic Surgery.

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML.

Protocol of a randomized, single-blind, controlled trial of an 18-month, home-based, high-intensity, exercise intervention in older, cognitively unimpaired APOE ε4 carriers.

Experience Group Insights of Obese Adults Aged 35-50 with Knee Osteoarthritis.

Body mass index changes and trajectories from midlife to late-life: association with subjective cognitive complaints in a 30-year Women's cohort study.

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.

Development of a Brief, Positively Framed Care Team Experience Measure.

Resistance and resilience to Alzheimer's disease in Down syndrome.

tet2 and tet3 regulate cell fate specification and differentiation events during retinal development.

Periorbital Dermatitis Induced by Apixaban.

Pattern separation involves regions beyond the hippocampus in non-demented elderly individuals: A 7T object lure task fMRI study.

Assessing the Relationship of Brain Metabolites to Cortical Thickness and Dementia Symptoms in Adults with Down Syndrome: A Pilot Study.

tet2 and tet3 regulate cell fate specification and differentiation events during retinal development.